ULTRAGENYX PHARMACEUTICAL INC. - COMMON STOCK
41.31
15-五月-24 14:24:32
15 分钟延时
股票
+0.34
+0.83%
今日范围
41.10 - 41.78
ISIN
N/A
来源
NASDAQ
-
09 10月 2023 08:00:00 条件 Nasdaq GlobeNewswire
-
Ultragenyx to Present Pipeline Update at Analyst Day on Monday, October 16, 2023
05 10月 2023 08:00:00 条件 Nasdaq GlobeNewswire
-
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
20 9月 2023 17:00:00 条件 Nasdaq GlobeNewswire
-
Ultragenyx to Participate at Investor Conferences in September
31 8月 2023 09:00:00 条件 Nasdaq GlobeNewswire
-
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
18 8月 2023 17:00:00 条件 Nasdaq GlobeNewswire
-
Ultragenyx Reports Second Quarter 2023 Financial Results and Corporate Update
03 8月 2023 16:00:00 条件 Nasdaq GlobeNewswire
-
31 7月 2023 08:00:01 条件 Nasdaq GlobeNewswire
-
Ultragenyx to Host Conference Call for Second Quarter 2023 Financial Results and Corporate Update
27 7月 2023 17:00:00 条件 Nasdaq GlobeNewswire
-
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
18 7月 2023 17:00:00 条件 Nasdaq GlobeNewswire
-
12 7月 2023 08:00:01 条件 Nasdaq GlobeNewswire
-
06 7月 2023 08:00:01 条件 Nasdaq GlobeNewswire
-
21 6月 2023 08:00:00 条件 Nasdaq GlobeNewswire
-
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
20 6月 2023 17:00:00 条件 Nasdaq GlobeNewswire
-
Ultragenyx to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference
07 6月 2023 17:00:00 条件 Nasdaq GlobeNewswire
-
05 6月 2023 16:00:53 条件 Nasdaq GlobeNewswire
-
Ultragenyx to Present at the 2023 Barclays - Gene Editing & Gene Therapy Summit
19 5月 2023 08:30:00 条件 Nasdaq GlobeNewswire
-
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
18 5月 2023 17:00:00 条件 Nasdaq GlobeNewswire
-
17 5月 2023 08:00:01 条件 Nasdaq GlobeNewswire
-
08 5月 2023 16:02:00 条件 Nasdaq GlobeNewswire
-
Ultragenyx to Present at Bank of America’s 2023 Health Care Conference
05 5月 2023 16:01:00 条件 Nasdaq GlobeNewswire